Primary |
Product Used For Unknown Indication |
80.0% |
Insomnia |
12.6% |
Depression |
6.3% |
Sleep Study |
1.1% |
|
Completed Suicide |
48.0% |
Insomnia |
8.0% |
Major Depression |
8.0% |
Cardio-respiratory Arrest |
4.0% |
Dyspnoea |
4.0% |
Hallucination |
4.0% |
Incoherent |
4.0% |
Mental Status Changes |
4.0% |
Psychotic Disorder |
4.0% |
Reflux Oesophagitis |
4.0% |
Type 1 Diabetes Mellitus |
4.0% |
Vasospasm |
4.0% |
|
Secondary |
Product Used For Unknown Indication |
48.9% |
Drug Use For Unknown Indication |
27.4% |
Insomnia |
4.3% |
Suicide Attempt |
4.3% |
Completed Suicide |
3.1% |
Nightmare |
1.9% |
Anxiety |
1.5% |
Major Depression |
1.5% |
Suicidal Ideation |
1.5% |
Depression |
1.2% |
Hallucination, Auditory |
1.2% |
Metastatic Malignant Melanoma |
1.0% |
Rheumatoid Arthritis |
1.0% |
Bursitis |
0.4% |
Psychotic Disorder |
0.3% |
Ear Infection |
0.1% |
Hormone Replacement Therapy |
0.1% |
Initial Insomnia |
0.1% |
Middle Insomnia |
0.1% |
|
Completed Suicide |
39.0% |
Respiratory Arrest |
16.5% |
Toxicity To Various Agents |
7.5% |
Poisoning |
4.5% |
Weight Increased |
4.5% |
Cardio-respiratory Arrest |
4.0% |
Death |
4.0% |
Thrombocytopenia |
4.0% |
Cardiac Arrest |
2.0% |
Drug Toxicity |
2.0% |
Mental Status Changes |
2.0% |
Sciatic Nerve Palsy |
2.0% |
Incoherent |
1.5% |
Intentional Drug Misuse |
1.5% |
Psychotic Disorder |
1.5% |
Middle Insomnia |
1.0% |
Toxic Encephalopathy |
1.0% |
Blood Bilirubin Increased |
0.5% |
Blood Creatine Phosphokinase Increased |
0.5% |
Cardiac Failure |
0.5% |
|
Concomitant |
Product Used For Unknown Indication |
40.0% |
Drug Use For Unknown Indication |
28.1% |
Depression |
5.4% |
Pain |
3.4% |
Insomnia |
3.4% |
Anxiety |
3.0% |
Rheumatoid Arthritis |
2.6% |
Hypertension |
2.6% |
Crohn's Disease |
1.8% |
Peritoneal Dialysis |
1.2% |
Gastrooesophageal Reflux Disease |
1.0% |
Hepatitis C |
1.0% |
Nausea |
1.0% |
Sleep Disorder |
0.9% |
Thrombosis Prophylaxis |
0.9% |
Type 2 Diabetes Mellitus |
0.8% |
Diffuse Large B-cell Lymphoma |
0.7% |
Blood Pressure |
0.7% |
Chest Pain |
0.7% |
Mineral Supplementation |
0.7% |
|
Vomiting |
20.5% |
Encephalopathy |
8.4% |
X-ray Abnormal |
7.2% |
Pneumonia |
6.0% |
Tremor |
6.0% |
Weight Decreased |
4.8% |
Wound Dehiscence |
4.8% |
Delirium |
3.6% |
Dyspnoea |
3.6% |
Hypersensitivity |
3.6% |
Pruritus |
3.6% |
Pulmonary Embolism |
3.6% |
Pyrexia |
3.6% |
Tooth Extraction |
3.6% |
Vein Disorder |
3.6% |
White Blood Cell Count Decreased |
3.6% |
Adverse Drug Reaction |
2.4% |
Asthenia |
2.4% |
Cardio-respiratory Arrest |
2.4% |
Cellulitis |
2.4% |
|
Interacting |
Pulmonary Arterial Hypertension |
100.0% |
|
|